127 related articles for article (PubMed ID: 1439632)
21. [Scleroderma and esophageal changes: treatment and instrumental control].
Altomare GF; Allara A; Pigatto PD
G Ital Dermatol Venereol; 1984; 119(4):263-6. PubMed ID: 6490099
[No Abstract] [Full Text] [Related]
22. [Treatment of acrosclerosis with cyclofenil].
Altomare GF; Zanotti M
Clin Ter; 1982 Mar; 100(6):597-603. PubMed ID: 7083788
[No Abstract] [Full Text] [Related]
23. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.
Rook AH; Freundlich B; Jegasothy BV; Perez MI; Barr WG; Jimenez SA; Rietschel RL; Wintroub B; Kahaleh MB; Varga J
Arch Dermatol; 1992 Mar; 128(3):337-46. PubMed ID: 1550365
[TBL] [Abstract][Full Text] [Related]
24. Effect of cyclofenil treatment on arterial insufficiency demonstrated in a patient by colour thermography.
Herbai G; Boczán J
Acta Med Scand; 1980; 207(1-2):127-30. PubMed ID: 7368965
[TBL] [Abstract][Full Text] [Related]
25. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
Clements PJ; Furst DE; Wong WK; Mayes M; White B; Wigley F; Weisman MH; Barr W; Moreland LW; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold JR
Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
[TBL] [Abstract][Full Text] [Related]
26. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin R; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold J
Arthritis Rheum; 1999 Nov; 42(11):2372-80. PubMed ID: 10555033
[TBL] [Abstract][Full Text] [Related]
27. D-penicillamine in systemic sclerosis? Yes!
Medsger TA; Lucas M; Wildy KS; Baker C
Scand J Rheumatol; 2001; 30(4):192-4. PubMed ID: 11578011
[TBL] [Abstract][Full Text] [Related]
28. Vesicular lesions in a woman with progressive systemic sclerosis. Penicillamine-induced intradermal vesicles: an example of human lathyrism.
Godar JM; Norins AL
Arch Dermatol; 1992 Jul; 128(7):977-8, 980-1. PubMed ID: 1626968
[No Abstract] [Full Text] [Related]
29. Cyclofenil-induced hemolytic anemia in scleroderma.
Russell ML; Schachter RK
Acta Med Scand; 1981; 210(5):431-2. PubMed ID: 7336999
[No Abstract] [Full Text] [Related]
30. Penicillamine therapy in systemic sclerosis.
Jayson MI; Lovell C; Black CM; Wilson RS
Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):82-8. PubMed ID: 122683
[TBL] [Abstract][Full Text] [Related]
31. D-penicillamine treatment in systemic sclerosis.
Steen V
J Rheumatol; 1991 Oct; 18(10):1435-7. PubMed ID: 1765965
[No Abstract] [Full Text] [Related]
32. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned.
Clements PJ; Seibold JR; Furst DE; Mayes M; White B; Wigley F; Weisman MD; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Wong WK
Semin Arthritis Rheum; 2004 Feb; 33(4):249-63. PubMed ID: 14978663
[TBL] [Abstract][Full Text] [Related]
33. Progressive systemic sclerosis (scleroderma).
JAMA; 1973 Apr; 224(5 Suppl):711-6. PubMed ID: 4739736
[No Abstract] [Full Text] [Related]
34. Hemolytic anemia during cyclofenil treatment of scleroderma.
Wollheim FA; Ljunggren HO; Blom-Bülow B
Acta Med Scand; 1981; 210(5):429-30. PubMed ID: 7039243
[No Abstract] [Full Text] [Related]
35. (D)-penicillamine treatment in systemic sclerosis (scleroderma). Effect on nutritional capillary circulation.
Mellstedt H; Fagrell B; Holm G; Björkholm M
Scand J Rheumatol; 1977; 6(2):92-6. PubMed ID: 897590
[TBL] [Abstract][Full Text] [Related]
36. Treatment of scleroderma heart by D-penicillamine.
Muers M; Stokes W
Br Heart J; 1976 Aug; 38(8):864-7. PubMed ID: 135572
[TBL] [Abstract][Full Text] [Related]
37. [D-penicillamine in the treatment of progressive systemic sclerosis].
Marques Neto JF; Manzato LC; Samara AM
AMB Rev Assoc Med Bras; 1980 Jun; 26(6):191-3. PubMed ID: 6970374
[No Abstract] [Full Text] [Related]
38. Systemic sclerosis-like lesions during long-term penicillamine therapy for Wilson's disease.
Miyagawa S; Yoshioka A; Hatoko M; Okuchi T; Sakamoto K
Br J Dermatol; 1987 Jan; 116(1):95-100. PubMed ID: 3814517
[TBL] [Abstract][Full Text] [Related]
39. Dermal elastin and collagen in systemic sclerosis. Effect of D-penicillamine treatment.
Pasquali Ronchetti I; Guerra D; Quaglino D; Vincenzi D; Manzini E; Canossi B; Manzini CU
Clin Exp Rheumatol; 1989; 7(4):373-83. PubMed ID: 2591110
[TBL] [Abstract][Full Text] [Related]
40. Bronchiolitis obliterans in a patient with localized scleroderma treated with D-penicillamine.
Boehler A; Vogt P; Speich R; Weder W; Russi EW
Eur Respir J; 1996 Jun; 9(6):1317-9. PubMed ID: 8804954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
